Director of the Laboratory of Immunology and Animal Biotechnology
Ghent University

Daisy Vanrompay graduated in 1990 as doctor in Veterinary Medicine at Ghent University. She became appointed as professor (UGent) in Immunology and Animal Biotechnology in 2000. D. Vanrompay is Director of the Laboratory of Immunology and Animal Biotechnology at Ghent University and Director of the National Diagnostic Reference Laboratory for C. psittaci infections in humans. She is a member of PROVAXS, the UGhent Center for Strategic Prophylaxis and Vaccine Development and of BLUEGENT, a business development center covering the field of Aquaculture and Blue Life Sciences. She is also a member of the UGent ‘One Health’ research consortium. Here research involves: i) the development of new molecular diagnostic methods for identifying bacterial pathogens in both humans and animals, ii) unravelling the cellular and molecular pathogenesis of bacterial infections, and iii) gaining insight in the induction of protective mucosal immunity. The laboratory focuses on Chlamydia infections in humans and animals, Escherichia coli infections in ruminants and chickens and Vibrio spp, Aeromonas spp., Providencia spp. and other bacterial infections in aquatic animals (fish and shrimp). In vitro and in vivo models are used to study bacterium host interactions for developing innovative diagnostics as well as prophylactic tools such as virulence blockers, novel antimicrobials, probiotics and innovative vaccines.

Other speakers

Sven Arnouts Business Development Manager Ghent University - Provaxs
Klaus Hellmann Head of EU-CRO Argenta
Johannes Charlier Managing Director Kreavet
Nathalie Vanderheijden Coordinator fot the European Partnership on Animal Health and Welfare Ghent University
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer-Ingelheim Animal Health
Sebastiaan Theuns CEO & co-founder PathoSense
Dieter Vancraeynest External Innovation Zoetis
Beatrice Vos Partner Stonehaven Cozmix Group (SC Group)
Bryan Charleston Director and CEO The Pirbright Institute
Stewart Burgess Head of Department of Vaccines & Diagnostics Moredun Research Institute
Inne Xhonneux Project Advisor Life Sciences Flanders Innovation & Entrepreneurship (VLAIO)
Kazuhiko Hirose President and Representative Director Meiji Animal Health Co., Ltd.
Hanjo Hennemann Co-founder and CEO Verovaccines
Juerg Baggenstoss Partner Stonehaven Cozmix Group
Paul Dick Founder and President Paul Dick and Associates
Steve Nanchen Head External Innovation - R&D Elanco Animal Health
Erwin Blomsma CEO and Co-Founder Benno Therapeutics
Alfonso Martín-Fontecha Business Development Manager Laboratorios SYVA
Valerio Abbadessa Research Programme Officer EC DG AGRI, F2 R&I
Paul Horwood UK Head of Farm & Exports IVC Evidensia
Jennifer Serriere-Di Bartolo Biopharma Strategic Collaboration & Marketing Manager Promega
Jens Radzimanowski Director of Antibody Therapeutics Lead Identification Boehringer Ingelheim
Pieter-Jan Serreyn Technical Director AnimalhealthEurope
Charles Owen Founder and CEO 272Bio Limited
Jeremy Gowler Chief Executive Officer Ophirex, Inc.
Ralf Herold Head of Regulatory Science and Academia, Task force Regulatory Science and Innovation, EMA European Medicines Agency
Ivo Claassen Deputy Executive Director - Head of Veterinary Medicines Division European Medicines Agency
Jeroen Hofenk Founder & CSO SwiftPharma
Ashiqul Haque Chief scientific officer Quantoom Biosciences
Xiao Shen CEO Canton Biologics
Paweł Wielgus Member of the Management Board Bioceltix
Bert Devriendt Professor Ghent University
Endre Kiss-Tóth Founder, CEO StemcellX Limited

Registrations are now open